1st Quarter - Report

THE MCMANUS GROUP for ZIMMER BIOMET

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 184 - Protection Medical Innovation Act of 2017. S. 108 - Medical Device Access and Innovation Protection. Sec. 211 of H.R. 1628 - American Health Care Act of 2017.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th), H.R. 184 (115th), S. 108 (115th)

Health Issues HCR

Legislation and FDA regulation concerning medical device development, manufacturing, commercialization, and post-market regulation and activities. S. 404 - A bill to amend the Federal Food, Drug, and Cosmetic Act to improve the process for inspections of device establishments for granting export certifications.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 404 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.